Semaglutide is designed to be released into the subcutaneous fat layer so it can be absorbed gradually
If you have severe side effects, such as vision changes, trouble swallowing, intense stomach pain, or an allergic reaction, seek medical attention immediately
Gastrointestinal Issues The most common side effects are related to the stomach and intestines, including: Nausea Vomiting Diarrhea Constipation These occur because semaglutide slows digestion, which can be an adjustment for your body
Inconsistent semaglutide dosing can compromise both treatment efficacy and safety
CagriSema cagrilintide 2.4 mg plus semaglutide 2.4 mg was submitted to the FDA on 18 December 2025 for chronic weight management, with the agency expected to review it during 2026
In the selected studies, participants were supplemented in a dose ranging from 1 g to 4,5 g per day for either 12 or 24 weeks, mostly by L-carnitine-L-tartrate (LCLT)